Literature DB >> 26293625

Ambulatory cardiac arrhythmias in relation to mild hypokalaemia and prognosis in community dwelling middle-aged and elderly subjects.

Nick Mattsson1, Golnaz Sadjadieh2, Preman Kumarathurai3, Olav Wendelboe Nielsen3, Lars Køber2, Ahmad Sajadieh3.   

Abstract

AIMS: Severe hypokalaemia can aggravate arrhythmia tendency and prognosis, but less is known about risk of mild hypokalaemia, which is a frequent finding. We examined the associations between mild hypokalaemia and ambulatory cardiac arrhythmias and their prognosis. METHODS AND
RESULTS: Subjects from the cohort of the 'Copenhagen Holter Study' (n = 671), with no history of manifest cardiovascular (CV) disease or stroke, were studied. All had laboratory tests and 48-h ambulatory electrocardiogram (ECG) recording. The median follow-up was 6.3 years. p-Potassium was inversely associated with frequency of premature ventricular complexes (PVCs) especially in combination with diuretic treatment (r = -0.22, P = 0.015). Hypokalaemia was not associated with supraventricular arrhythmias. Subjects at lowest quintile of p-potassium (mean 3.42, range 2.7-3.6 mmol/L) were defined as hypokalaemic. Cardiovascular mortality was higher in the hypokalaemic group (hazard ratio and 95% confidence intervals: 2.62 (1.11-6.18) after relevant adjustments). Hypokalaemia in combination with excessive PVC worsened the prognosis synergistically; event rates: 83 per 1000 patient-year in subjects with both abnormalities, 10 and 15 per 1000 patient-year in those with one abnormality, and 3 per 1000 patient-year in subjects with no abnormality. One variable combining hypokalaemia with excessive supraventricular arrhythmias gave similar results in univariate analysis, but not after multivariate adjustments.
CONCLUSION: In middle-aged and elderly subjects with no manifest heart disease, mild hypokalaemia is associated with increased rate of ventricular but not supraventricular arrhythmias. Hypokalaemia interacts synergistically with increased ventricular ectopy to increase the risk of adverse events. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Arrhythmias; Atrial premature complexes; Hypokalaemia; Mortality; Ventricular premature complexes

Mesh:

Substances:

Year:  2015        PMID: 26293625     DOI: 10.1093/europace/euv204

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

1.  Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study.

Authors:  Yan Chen; Alex R Chang; Mara A McAdams DeMarco; Lesley A Inker; Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh; Morgan E Grams
Journal:  Mayo Clin Proc       Date:  2016-08-04       Impact factor: 7.616

2.  Race, Serum Potassium, and Associations With ESRD and Mortality.

Authors:  Yan Chen; Yingying Sang; Shoshana H Ballew; Adrienne Tin; Alex R Chang; Kunihiro Matsushita; Josef Coresh; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Morgan E Grams
Journal:  Am J Kidney Dis       Date:  2017-03-28       Impact factor: 8.860

3.  Association of Serum Potassium Levels with Mortality and Cardiovascular Events: Findings from the Chinese Multi-provincial Cohort Study.

Authors:  Shuai Liu; Dong Zhao; Miao Wang; Yue Qi; Jiayi Sun; Jun Liu; Yan Li; Jing Liu
Journal:  J Gen Intern Med       Date:  2021-09-10       Impact factor: 6.473

4.  Effect of Hypokalemia on Functional Outcome at 3 Months Post-Stroke Among First-Ever Acute Ischemic Stroke Patients.

Authors:  Fan Gao; Cheng-Tai Wang; Chen Chen; Xing Guo; Li-Hong Yang; Xian-Cang Ma; Jian-Feng Han
Journal:  Med Sci Monit       Date:  2017-06-10

5.  Development of a preoperative index-based nomogram for the prediction of hypokalemia in patients with pituitary adenoma: a retrospective cohort study.

Authors:  Wenpeng Li; Lexiang Zeng; Deping Han; Shanyi Zhang; Bingxi Lei; Meiguang Zheng; Yuefei Deng; Lili You
Journal:  PeerJ       Date:  2021-07-19       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.